Century is advancing a robust portfolio of allogeneic iNK and iT cell therapy product candidates across solid tumor and hematologic malignancies. Century Therapeutics, Inc. engages in the development of off-the-shelf cell therapies to advance the course of cancer care. It focuses on harnessing the power. IPSC Century Therapeutics · High. · Low. · Volume. K · Open. · Pre Close. · Turnover. K · Turnover Ratio. % · P/E . Discover real-time Century Therapeutics, Inc. Common Stock (IPSC) stock prices, quotes, historical data, news, and Insights for informed trading and. Century Therapeutics Inc stock price live, this page displays NASDAQ IPSC stock exchange data. View the IPSC premarket stock price ahead of the market session.
Key Stock Data · P/E Ratio (TTM). N/A · EPS (TTM). $ · Market Cap. $ M · Shares Outstanding. M · Public Float. M · Yield. IPSC is not. IPSC - Century Therapeutics, Inc. (NasdaqGS) - Share Price and News. Today's High; $ Today's Low; $ 52 Week High; $ 52 Week Low; $ Data Provided by Refinitiv. Minimum 15 minutes delayed. (NASDAQ: IPSC) Century Therapeutics stock price per share is $ today (as of Aug 23, ). The 22 analysts offering price forecasts for Century Therapeutics have a median target of , with a high estimate of and a low estimate of Lineage Cell Therapeutics Inc. $ LCTX % ; Caesarstone Ltd. $ CSTE % ; Regulus Therapeutics Inc. $ RGLS % ; ATAI Life Sciences NV. $ Century Therapeutics Inc IPSC:NASDAQ · Open · Day High · Day Low · Prev Close · 52 Week High · 52 Week High Date03/08/24 · 52 Week Low Century Therapeutics Inc. ; Open. $ Previous Close ; YTD Change. %. 12 Month Change ; Day Range · 52 Wk Range. Century Therapeutics, Inc., a biotechnology company, develops transformative allogeneic cell therapies for the treatment of solid tumor and hematological. The Investor Relations website contains information about Century Therapeutics.'s business for stockholders, potential investors, and financial analysts. 09, (GLOBE NEWSWIRE) -- Century Therapeutics, Inc. (NASDAQ: IPSC), an innovative clinical-stage biotechnology company developing induced pluripotent stem.
Stock analysis for Century Therapeutics Inc (D:US) including stock price, stock chart, company news, key statistics, fundamentals and company. Century Therapeutics is on a mission to develop innovative allogeneic, iPSC-derived NK and T cell therapies that are more effective, tolerable, accessible. Century Therapeutics (IPSC) delivered earnings and revenue surprises of 10% and %, respectively, for the quarter ended March Century Therapeutics, Inc. Stock · Equities · IPSC · UST · Biotechnology & Medical Research · Valuation: Century Therapeutics, Inc. · Chart: Century. Week of August 26, ; Open Price: $ ; Closing Price: $ ; Day's High: $ ; Day's Low: $ ; Volume: , IPSC's current price target is $ Learn why top analysts are making this stock forecast for Century Therapeutics at MarketBeat. The average price target is $ with a high forecast of $ and a low forecast of $ The average price target represents a % change from the. Century Therapeutics Inc. analyst ratings, historical stock prices, earnings estimates & actuals. IPSC updated stock price target summary. Century Therapeutics, Inc. engages in the development of off-the-shelf cell therapies to advance the course of cancer care. It focuses on harnessing the.
Century Therapeutics Statistics · Share Statistics. IPSC has million shares outstanding. · Valuation Ratios. PE Ratio · Enterprise Valuation. EV /. Century Therapeutics started at overweight with $40 stock price target at J.P. Morgan. Jul. 13, at a.m. ET by Tomi Kilgore. PHILADELPHIA, Nov. 10, (GLOBE NEWSWIRE) -- Century Therapeutics, Inc. (NASDAQ: IPSC), an innovative biotechnology company developing induced pluripotent. Century Therapeutics Inc Stock Price (IPSC). Century Therapeutics Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker IPSC. The. Century Therapeutics (IPSC) has a Smart Score of 6 based on an analysis of 8 unique data sets, including Analyst Recommendations, Crowd Wisdom.
SEC Filings ; Aug 05, , Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing ; Jul 31, , 4. Statement. Get Century Therapeutics Inc (IPSC) share price, real-time stock quotes, historical charts and financial information. Start Investing in Century. A biotechnology company, engages in the development of genetically engineered allogeneic cell therapies for the treatment of solid tumor and hematological. Earnings for Century Therapeutics are expected to decrease in the coming year, from ($) to ($) per share. Price to Earnings Ratio vs. the Market. The P/. Buying or selling a stock that's not traded in your local currency? Don't let the currency conversion trip you up. Convert Century Therapeutics Inc stocks or.